SebiaUSA (@SebiaUS) header
SebiaUSA (@SebiaUS) profile picture

Sebia is the world’s leading provider of clinical protein electrophoresis equipment and reagents, a technology used for in-vitro diagnostic (IVD) testing.

Norcross, GA
Joined December 2012
Photo by SebiaUSA (@SebiaUS)Photo by SebiaUSA (@SebiaUS)Photo by SebiaUSA (@SebiaUS)Photo by SebiaUSA (@SebiaUS)Photo by SebiaUSA (@SebiaUS)Photo by SebiaUSA (@SebiaUS)Photo by SebiaUSA (@SebiaUS)Photo by SebiaUSA (@SebiaUS)Photo by SebiaUSA (@SebiaUS)Photo by SebiaUSA (@SebiaUS)
🚨 CALLING ALL Pathologists & Laboratories: reduce variability, identify optimal testing, & improve the accurate diagnosis of patients with #monoclonalgammopathies: capatholo.gy/37pyXHz.
3
3
SebiaUSA retweeted
EXCITING NEWS! The CAPILLARYS 3 OCTA is now available! Click here to learn more: ow.ly/2sQY50xpA3u #sebiausa #sebia #C3O
GSK's anti-BCMA drug hits goal in pivotal multiple myeloma test fiercebiotech.com/biotech/gs…
1
7
27
Multiple myeloma is caused by DNA changes in plasma cells. The exact cause of these changes is not yet known, but great progress is being made to find out #FactFriday
4
4
The #2019AACC mobile app is now available to download in both the Apple Store and Google Play. The app is a great way to build an itinerary, search for sessions, find exhibitors and more. 2019aacc.org/app
The 71st AACC Annual Scientific Meeting & Clinical Lab Expo showcases cutting edge science and technology shaping the future of laboratory medicine. Join us in Anaheim, California, from August 4-8. 2019aacc.org/ #2019AACC youtu.be/lOUddK9dsxk
1
5
2
16
When we improve diagnosis beyond current practice, we decrease both false negative and false positive classifications. Reducing false negatives for dangerous diseases saves lives, while reducing false positives for benign diseases saves money. https://teapawt.net/t.co/Hh7p6N2Znd
9
13
The AACR Future of Cancer Research Innovation Summit on Combination Therapies ends today. We thank this amazing team of leaders in immunotherapy, targeted drug therapies, surgical oncology, & radiation therapy for working to improve the development of combination cancer therapies
1
13
2
37
ESL invites you to attend the Sebia Scientific Focus Group in conjunction with ADA 79th Scientific Sessions. The Sebia focus group "Is HbA1c for everyone?" will focus on the medical added values offered by Sebia's HbA1c capillary electrophoresis technology #Sebia #diabetes #HbA1c
Evaluation of the Sebia Free Light Chain assay: comparison with the Freelite assay for the clinical management of diagnosis, response and relapse assessment in multiple myeloma clinical-lymphoma-myeloma-le… – at Duluth, GA
1
1
Thank you for the magnificent view from #2017AACC @SebiaUS
1
4